Pepke-ZabaJ, HigenbottamTW, Dinh-XuanAT, StoneD, WallworkJ.Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet1991;338(8776):1173–1174.
2.
RobertsJD, PolanerDM, LangP, ZapolWM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818–819.
3.
KinsellaJP, NeishSR, ShafferE, AbmanSH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):819–820.
4.
RobertsJDJr, FinemanJR, MorinFC3rd, ShaulPW, RimarS, SchreiberMD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. New Engl J Med1997;336(9):605–610.
5.
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. New Engl J Med1997;336(9):597–604.
6.
ArtigasA, BernardGR, CarletJ, DreyfussD, GattinoniL, HudsonL, et al. The American-European Consensus Conference on ARDS. Part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling: acute respiratory distress syndrome (review). Am J Respir Crit Care Med1998;157:1332–1347.
7.
RossaintR, FalkeKJ, LopezF, SlamaK, PisonU, ZapolWM. Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med1993;328(6):399–405.
8.
BigatelloLM, HurfordWE, KacmarekRM, RobertsJDJr, ZapolWM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary hemodynamics and oxygenation. Anesthesiology1994;80(4):761–770.
9.
Chollet-MartinS, GatecelC, KermarrecN, Gougerot-PocidaloMA, PayenDM. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med1996;153(3):985–990.
10.
KavanaghBP, MouchawarA, GoldsmithJ, PearlRG. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol1994;76(3):1324–1329.
11.
Barbotin-LarrieuF, MazmanianM, BaudetB, DetruitH, ChapelierA, LibertJM, et al. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol1996;80(3):782–788.
12.
ManktelowC, BigatelloLM, HessD, HurfordWE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology1997;87(2):297–307.
13.
DellingerRP, ZimmermanJL, TaylorRW, StraubeRC, HauserDL, CrinerGJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med1998;26(1):15–23.
14.
MichaelJR, BartonRG, SaffleJR, MoneM, MarkewitzBA, HillierK, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med1998;157(5 Pt 1):1372–1380.
FullertonDA, JonesSD, JaggersJ, PiedalueF, GroverFL, McIntyreRCJr. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation. J Thorac Cardiovasc Surg1996;111(4):753–763.
19.
SemigranMJ, CockrillBA, KacmarekR, ThompsonBT, ZapolWM, DecGW, FiferMA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol1994;24(4):982–988.
20.
LohE, StamlerJS, HareJM, LoscalzoJ, ColucciWS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation1994;90(6):2780–2785.
21.
ChannickRN, NewhartJW, JohnsonFW, MoserKM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. A practical nitric oxide delivery and monitoring system. Chest1994;105(6):1842–1847.
22.
SnellGI, SalamonsenRF, BerginP, EsmoreDS, KhanS, WilliamsTJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med1995;151(4):1263–1266.
23.
AdnotS, KouyoumdjianC, DefouilloyC, AndrivetP, SediameS, HerigaultR, FratacciMD. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis1993;148(2):310–316.
24.
BarberaJA, RogerN, RocaJ, RoviraI, HigenbottamTW, Rodriguez-RoisenR.Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet1996;347(8999):436–440.
25.
ScherrerU, VollenweiderL, DelabaysA, SavcicM, EichenbergerU, KlegerGR, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med1996;334(10):624–629.
26.
AdrieC, BlochKD, MorenoPR, HurfordWE, GuerreroJL, HoltR, et al. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation1996;94(8):1919–1926.
27.
BachaEA, HerveP, MurakamiS, ChapelierA, MazmanianGM, de MontprevilleV, et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg1996;112(3):590–598.
28.
KavanaghBP, PearlRG. Inhaled nitric oxide in anesthesia and critical care medicine (review). Int Anesthesiol Clin1995;33(1):181–210.
29.
ForsterS, WoditschI, SchroderH, SchrorK.Reduced nitric oxide release causes nitrate tolerance in the intact coronary circulation. J Cardiovasc Pharmacol1991;17(6):867–872.
30.
KooyNW, RoyallJA, YeYZ, KellyDR, BeckmanJS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med1995;151(4):1250–1254.
31.
PutensenC, RasanenJ, LopezFA, DownsJB. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest1994;106(5):1563–1569.
32.
ZapolWM, JonesR.Vascular components of ARDS: clinical pulmonary hemodynamics and morphology. Am Rev Respir Dis1987;136(2):471–474.
33.
RavichandranLV, JohnsRA, RengasamyA.Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol1995;268(6 Pt 2):H2216–H2223.
34.
StewartTE, ValenzaF, RibeiroSP, WenerAD, VolgyesiG, MullenJB, SlutskyAS. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med1995;151(3 Pt 1):713–718.
35.
KrafftP, FridrichP, FitzgeraldRD, KocD, SteltzerH.Effectiveness of nitric oxide inhalation in septic ARDS. Chest1996;109(2): 486–493.
36.
HolzmannA, BlochKD, SanchezLS, FilippovG, ZapolWM. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol1996;271(6 Pt 1):L981–L986.
37.
IgnarroLJ. Signal transduction mechanisms involving nitric oxide (review). Biochem Pharmacol1991;41(4):485–490.
38.
GerlachH, RossaintR, PappertD, FalkeKJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest1993;23(8):499–502.
McMahonTJ, IgnarroLJ, KadowitzPJ. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol1993;74(4):1704–1711.
41.
ThusuKG, MorinFC3rd, RussellJA, SteinhornRH. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med1995;152(5 Pt 1):1605–1610.
42.
ZieglerJW, IvyDD, FoxJJ, KinsellaJP, ClarkeWR, AbmanSH. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med1998;157(4 Pt 1):1104–1110.
43.
IchinoseF, AdrieC, HurfordWE, ZapolWM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J Appl Physiol1995;78(4):1288–1295.
GoldsteinI, LueTF, Padma-NathanH, RosenRC, SteersWD, WickerPA. Oral sildenafil in the treatment of erectile dysfunction. The Sildenafil Study Group. N Eng J Med1998;338(20):1397–1404.
46.
KinsellaJP, TorielliF, ZieglerJW, IvyDD, AbmanSH. Dipyridamole augmentation of response to nitric oxide (letter). Lancet1995;346(8975):647–648.
47.
FullertonDA, JaggersJ, PiedalueF, GroverFL, McIntyreRCJr. Effective control of refractory pulmonary hypertension after cardiac operations. J Thorac Cardiovasc Surg1997;113(2):363–370.
48.
AdrieC, IchinoseF, HolzmannA, KeeferL, HurfordWE, ZapolWM. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J Appl Physiol1998;84(2):435–441.
49.
BrilliRJ, Krafte-JacobsB, SmithDJ, RoselleD, PasseriniD, VromenA, et al. Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J Appl Physiol1997;83(6):1968–1975.
50.
AdrieC, HiraniWM, HolzmannA, KeeferL, ZapolWM, HurfordWE. Selective pulmonary vasodilation by intravenous infusion of an ultrashort half-life nucleophile/nitric oxide adduct. Anesthesiology1998;88(1):190–195.
51.
ZhuGF, SunB, NiuSF, CaiYY, LinK, LindwallR, RobertsonB.Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med1998;158(2):437–443.
52.
WilcoxDT, GlickPL, KaramanoukianHL, MorinFC3rd, FuhrmanBP, LeachC.Partial liquid ventilation and nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg1997;32(8):1211–1215.
53.
ChatteG, SabJ-M, DuboisJ-M, SirodotM, GaussorguesP, RobertD.Prone position in mechanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med1997;155(2):473–478.
54.
PapazianL, BregeonF, GaillatF, ThirionX, GainnierM, GregoireR, et al. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med1998;157(2):580–585.
55.
PisonU, LopezFA, HeidelmeyerCF, RossaintR, FalkeKJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol1993;74(3):1287–1292.
56.
DreyfussD, DjedainiK, LanoreJ-J, MierL, FroidevauxR, CosteF.A comparative study of the effects of almitrine bimesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia. Am Rev Respir Dis1992;146(2):295–299.
57.
WysockiM, DelclauxC, RoupieE, LangeronO, LiuN, HermanB, LemaireF, BrochardL.Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bimesylate in the adult respiratory distress syndrome. Intensive Care Med1994;20(4):254–259.
58.
PayenDM, GatecelC, PlaisanceP.Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome (letter). Lancet1993;341(8861):1664.
59.
PayenD, MuretJ, BeloucifS, GatecelC, KermarrecN, GuinardN, MateoJ.Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions. Anesthesiology1998;89(5):1157–1165.
60.
DoeringEB, HansonCW3rd, ReilyDJ, MarshallC, MarshallBE. Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology1997;87(1):18–25.
61.
GoldsteinDJ, DeanDA, SmerlingA, OzMC, BurkhoffD, DicksteinML. Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg1997;114(3):461–466.
